Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ribera

Showing results (281-290 of 310) with videos related to

Pageof 31
Sort By:
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Age and Ageing|June 1, 1999
Declaration of Yuste. European Working PartyM Lye, J L Vega Vega, J F Macías Nuñez, et al.
Leukemia|April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AMLJ F Nomdedéu, M Hoyos, M Carricondo, et al.
Medicina Clinica|May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]C Rozman, E Carreras, J Sierra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS riskM Spina, Z Nagy, J M Ribera, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.
Haematologica|June 22, 2001
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIALJ J Ortega, J M Ribera, A Oriol, et al.
Blood|November 11, 1999
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA groupM A Sanz, G Martín, C Rayón, et al.
Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.
Pageof 31

Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Age and Ageing|June 1, 1999
Declaration of Yuste. European Working PartyM Lye, J L Vega Vega, J F Macías Nuñez, et al.
Leukemia|April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AMLJ F Nomdedéu, M Hoyos, M Carricondo, et al.
Medicina Clinica|May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]C Rozman, E Carreras, J Sierra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS riskM Spina, Z Nagy, J M Ribera, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.
Haematologica|June 22, 2001
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIALJ J Ortega, J M Ribera, A Oriol, et al.
Blood|November 11, 1999
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA groupM A Sanz, G Martín, C Rayón, et al.
Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.
Pageof 31